Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Speciality Medicines Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Speciality Medicines Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Speciality Medicines has submitted to BSE the Shareholding Pattern for the Period Ended March 27, 2026

    30 Mar 2026, 2:10PM As of March 2026, 43.43% is owned by Indian Promoters and 56.57% by Public. <p align=justify> Top five Promoters holding highest number of shares of S
  • Speciality Medicines Ltd. debuts with 0.00% discount at Rs 124.00

    30 Mar 2026, 10:20AM Speciality Medicines Ltd. makes a flat debut on the bourses with scrip got listed at Rs 124.00 on the Bombay Stock Exchange, a 0.00 per cent discount
  • Speciality Medicines - Listing of Equity Shares of Speciality Medicines Ltd

    30 Mar 2026, 8:09AM Trading Members of the Exchange are hereby informed that effective from March 30, 2026, the Equity Shares of Speciality Medicines Ltd (Scrip Code: 54
  • Speciality Medicines announces launch of initial public offering

    17 Mar 2026, 4:00PM Speciality Medicines Ltd. has announced public offering of 2350000 shares at a price of Rs 10.00 each for Cash at a Premium of Rs 114.00 per share. Th

Key fundamentals

Evaluate the intrinsic value of Speciality Medicines Ltd stock 

Name March-25 March-24 March-23
Assets 35.4633 17.9222 9.509
Liabilities 35.4633 17.9222 9.509
Equity 6.4358 5.1168 3.8201
Gross Profit 9.0921 5.2608 3.5655
Net Profit 8.6082 2.9336 1.6889
Cash From Operating Activities -5.7944 -4.8002 -4.2148
NPM(%) 14.77 10.65 7.26
Revenue 58.2714 27.5248 23.2408
Expenses 49.1793 22.264 19.6753
ROE(%) 22.17 7.55 4.35

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Speciality Medicines Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 723.95 -0.84 43.47 88.63 301.39 0.68
Lotus Eye Hospital and Institute Ltd 107.15 -0.79 346.71 322.97 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 17.07 1.73 0.00 670.59 -39.50 0.00
Astec Lifesciences Ltd 659.70 17.71 0.00 304.56 -604.75 0.00

Company Info

Our Company was originally incorporated as "Speciality Medicines Private Limited" as a Private Limited Company, under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre. Later on, pursuant to a special resolution passed by our Shareholders in the ExtraOrdinary General Meeting held on April 04, 2024, our Company was converted from a private limited company to public limited company and consequently, the name of our Company was changed from "Speciality Medicines Private Limited" to "Speciality Medicines Limited" and a fresh certificate of incorporation dated June 25, 2024 was issued to our Company by the Registrar of Companies, Central Registration Centre. The Corporate Identification Number of our Company is U85300GJ2021PLC120022. MAJOR EVENTS:2021- Incorporation of our company viz. "Speciality Medicines Private Limited".- Our Company shifted its operation to Mumbai, Maharashtra, India2022- Our Company was recognized as Start-up by Department for Promotion of Industry and Internal Trade2023- Our Company received certificate as an eligible business by Inter-Ministerial Board to avail Income Tax benefits under Section 80-IAC of the Income Tax Act, 1961.2024- Conversion of our Company from Private Limited to Public Limited Company.

Our Company was originally incorporated as "Speciality Medicines Private Limited" as a Private Limited Company, under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre. Later on, pursuant to a special resolution passed by our Shareholders in the ExtraOrdinary General Meeting held on April 04, 2024, our Company was converted from a private limited company to public limited company and consequently, the name of our Company was changed from "Speciality Medicines Private Limited" to "Speciality Medicines Limited" and a fresh certificate of incorporation dated June 25, 2024 was issued to our Company by the Registrar of Companies, Central Registration Centre. The Corporate Identification Number of our Company is U85300GJ2021PLC120022. MAJOR EVENTS:2021- Incorporation of our company viz. "Speciality Medicines Private Limited".- Our Company shifted its operation to Mumbai, Maharashtra, India2022- Our Company was recognized as Start-up by Department for Promotion of Industry and Internal Trade2023- Our Company received certificate as an eligible business by Inter-Ministerial Board to avail Income Tax benefits under Section 80-IAC of the Income Tax Act, 1961.2024- Conversion of our Company from Private Limited to Public Limited Company.

Read More

Parent Organisation

Speciality Medicines Ltd.

Founded

05/02/2021

Managing Director

Mr.Parthkumar Goyani

NSE Symbol

FAQ

The current price of Speciality Medicines Ltd is

The 52-week high for Speciality Medicines Ltd is

The market capitalization of Speciality Medicines Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Speciality Medicines Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Speciality Medicines Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Speciality Medicines Ltd shares.

The CEO of Speciality Medicines Ltd is Mr.Parthkumar Goyani, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT